The FDA remains a powerful driver of change in pharmacy practice through its approvals, policies, and public health actions. This episode highlights timely FDA developments and emerging areas of focus that pharmacists need to be aware of—from regulatory shifts to new communication initiatives. Tune in to stay informed on FDA activity that could influence the way you practice and care for patients.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Mary Ross Southworth, PharmD
Principal
S&S Consulting Partners

Joshua Davis Kinsey has no relevant financial relationships to disclose.
Mary Ross Southworth is a consultant for Travere, Unicycive, Liquidia, and Mineralys. All relevant financial relationships have been mitigated. 


CPE REDEMPTION
This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

• If you are already enrolled in this course, click here to redeem your credit. 
• To purchase this episode and claim your CPE credit, click here. 

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Recognize current FDA topics and areas of focus relevant to pharmacy practice.
2. Describe how current FDA priorities may impact medication use, pharmacist responsibilities, or patient care.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-296-H03-P
Initial release date: 9/22/2025
Expiration date: 9/22/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram